PMC:7214327 / 654-4378
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 1131-1141 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T3 | 1247-1250 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T4 | 1261-1264 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T5 | 1339-1342 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T6 | 1597-1607 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T7 | 1625-1628 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T8 | 1748-1758 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T9 | 1800-1803 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T10 | 1819-1830 | Body_part | denotes | nucleotides | http://purl.org/sig/ont/fma/fma82740 |
T11 | 2599-2602 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T12 | 2670-2676 | Body_part | denotes | serine | http://purl.org/sig/ont/fma/fma82764 |
T13 | 2846-2849 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T14 | 3219-3222 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T15 | 3346-3349 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T16 | 3668-3672 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T5 | 21-29 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 64-72 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 98-108 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
T8 | 963-968 | Disease | denotes | Ebola | http://purl.obolibrary.org/obo/MONDO_0005737 |
T9 | 1088-1092 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T10 | 1445-1453 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 1458-1466 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T12 | 2107-2115 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T13 | 2120-2128 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T14 | 3067-3075 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T15 | 3144-3152 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T16 | 3188-3196 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T17 | 3520-3535 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T18 | 3526-3535 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 43-44 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 204-205 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 516-517 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 638-643 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T5 | 675-676 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 700-701 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T7 | 771-772 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 897-898 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 928-936 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T10 | 950-957 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T11 | 1015-1020 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T12 | 1042-1043 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T13 | 1129-1130 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T14 | 1220-1221 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T15 | 1300-1303 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T16 | 1356-1357 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T17 | 1484-1487 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T18 | 1655-1658 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T19 | 1712-1713 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T20 | 1926-1929 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T21 | 2042-2049 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T22 | 2205-2208 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T23 | 2307-2308 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T24 | 2379-2380 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T25 | 2523-2524 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T26 | 2627-2630 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T27 | 2801-2802 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T28 | 2915-2922 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T29 | 3011-3012 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T30 | 3079-3081 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T31 | 3154-3160 | http://purl.obolibrary.org/obo/CLO_0001236 | denotes | 2. (A) |
T32 | 3268-3269 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T33 | 3415-3416 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T34 | 3449-3457 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T35 | 3490-3491 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T36 | 3567-3572 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T37 | 3616-3617 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T38 | 3668-3672 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T9 | 367-371 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T10 | 583-588 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T11 | 692-696 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T12 | 750-754 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T13 | 858-863 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T14 | 867-877 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T15 | 1131-1141 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T16 | 1164-1176 | Chemical | denotes | triphosphate | http://purl.obolibrary.org/obo/CHEBI_18036 |
T17 | 1200-1202 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T18 | 1511-1513 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T19 | 1537-1559 | Chemical | denotes | Adenosine triphosphate | http://purl.obolibrary.org/obo/CHEBI_15422 |
T20 | 1537-1546 | Chemical | denotes | Adenosine | http://purl.obolibrary.org/obo/CHEBI_16335 |
T21 | 1547-1559 | Chemical | denotes | triphosphate | http://purl.obolibrary.org/obo/CHEBI_18036 |
T22 | 1561-1564 | Chemical | denotes | ATP | http://purl.obolibrary.org/obo/CHEBI_15422|http://purl.obolibrary.org/obo/CHEBI_30616 |
T24 | 1566-1574 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
T25 | 1597-1607 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T26 | 1681-1695 | Chemical | denotes | hydroxyl group | http://purl.obolibrary.org/obo/CHEBI_43176 |
T27 | 1681-1689 | Chemical | denotes | hydroxyl | http://purl.obolibrary.org/obo/CHEBI_29191 |
T28 | 1690-1695 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T29 | 1703-1705 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T30 | 1748-1758 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T31 | 1819-1830 | Chemical | denotes | nucleotides | http://purl.obolibrary.org/obo/CHEBI_36976 |
T32 | 1888-1890 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T33 | 2372-2374 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T34 | 2670-2684 | Chemical | denotes | serine residue | http://purl.obolibrary.org/obo/CHEBI_32848 |
T35 | 2670-2676 | Chemical | denotes | serine | http://purl.obolibrary.org/obo/CHEBI_17822 |
T36 | 2988-2990 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 1339-1352 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T5 | 1343-1352 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T6 | 1625-1638 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T7 | 1629-1638 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T8 | 1781-1790 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
T9 | 1800-1813 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T10 | 1804-1813 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T11 | 2599-2612 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T12 | 2603-2612 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T13 | 2846-2859 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T14 | 2850-2859 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T15 | 3219-3232 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T16 | 3223-3232 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T17 | 3327-3336 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T18 | 3520-3535 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 0-75 | Sentence | denotes | The current pandemic COVID-19 is caused by a novel coronavirus, SARS-CoV-2. |
T12 | 76-238 | Sentence | denotes | The disease is highly infectious like other coronaviral disease and causing already more than 2.3 lacs deaths worldwide, posing a serious threat to mankind (1,2). |
T13 | 239-422 | Sentence | denotes | Scientists, doctors and other health professional are working very hard to combat this current situation, but still there is no drug or vaccine available to treat this morbid disease. |
T14 | 423-482 | Sentence | denotes | But researchers are trying to develop new therapeutics (3). |
T15 | 483-844 | Sentence | denotes | However this situation initiates a global effort to find out effective measures or discovery of new drugs or vaccines to stop the spreading of this deadly virus, but, since the development of a new vaccine or drug is a time-consuming process, repurposing of existing drug could be act as a brilliant alternative with potential to combat the disease effectively. |
T16 | 845-1114 | Sentence | denotes | One of these drugs is remdesivir (RDV), which shows a broad spectrum of anti-viral activity against many viruses like Ebola (4,5), Nipah (6, 7, 8), respiratory syncytial virus (RSV) family (8) and a diverse category of coronaviruses including SARS CoV and MERS CoV (9). |
T17 | 1115-1480 | Sentence | denotes | Remdesivir is a nucleotide analogue (4), and the triphosphate form of RDV, i.e., RDV-TP is being used as a substrate for many viral RNA-dependent RNA polymerase (RdRp) complexes and it has been reported to inhibit the viral RNA synthesis by a specific mechanism of delayed chain termination for all three coronaviruses (MERS-CoV, SARS-CoV and SARS-CoV-2) RdRp (10). |
T18 | 1481-1651 | Sentence | denotes | It has been observed that RDV-TP resembles specifically Adenosine triphosphate (ATP) molecule and competes with the nucleotide during the viral RNA synthesis (Figure 1 ). |
T19 | 1652-1912 | Sentence | denotes | It has been reported that 3′ hydroxyl group of RDV-TP forms a phosphodiester bond with the next nucleotide but it terminates the formation of viral RNA synthesis at 3 nucleotides downstream, precisely at i + 3 position, whereas the RDV-TP is the i-th position. |
T20 | 1913-2187 | Sentence | denotes | Moreover, it has also been fascinating to note that the underlying mechanism of chain termination is more or less common in many viruses including all the recent coronaviruses, namely MERS-CoV, SARS-CoV and SARS-CoV-2, though the precise molecular mechanism remains elusive. |
T21 | 2188-2408 | Sentence | denotes | Additionally, it has been reported very recently that the main reason of chain termination at i + 4 position is due to a steric clash between 1′-CN substituent of the incorporated RDV-TP and a specific residue S861 (10). |
T22 | 2409-2613 | Sentence | denotes | It is consistent with the chain termination at i + 3 position due to the imposed inability of RdRp to translocate a single position downstream, so eventually it terminates the nascent viral RNA synthesis. |
T23 | 2614-2719 | Sentence | denotes | Moreover, it has also been imperative to note that this serine residue is conserved in all coronaviruses. |
T24 | 2720-2860 | Sentence | denotes | Though, the actual molecular mechanism is still not very clear but this could be a plausible explanation of termination viral RNA synthesis. |
T25 | 2861-3083 | Sentence | denotes | Recently, scientists also expressed RdRp of different viruses and measure kinetic parameters to infer its interaction with RDV-TP and also determined a score of 0.77 mmol half maximal concentration against SARS-CoV-2 (11). |
T26 | 3084-3350 | Sentence | denotes | Figure 1 Probable molecular mechanism of Remdisivir against SARS-CoV- 2. (A) Thematic diagram shows the SARS-CoV-2 viral entry and its RNA synthesis which can be block by Remdisivir. (B) Detail molecular mechanism of Remdisivir to inhibit the synthesis of viral RNA. |
T27 | 3351-3724 | Sentence | denotes | It can be concluded that this chain termination method could be a general mechanism of anti-viral activity of this particular substrate to a broad spectrum of different viral infection, but still the availability of human trial and safety data is pending, and also a detailed anti-viral profiling of this compound in cell culture study is highly appreciated at this moment. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
21 | 45-62 | Species | denotes | novel coronavirus | Tax:2697049 |
22 | 64-74 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
23 | 120-131 | Species | denotes | coronaviral | Tax:11118 |
24 | 21-29 | Disease | denotes | COVID-19 | MESH:C000657245 |
25 | 179-185 | Disease | denotes | deaths | MESH:D003643 |
31 | 3144-3155 | Species | denotes | SARS-CoV- 2 | Tax:2697049 |
32 | 3188-3198 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
33 | 3125-3135 | Chemical | denotes | Remdisivir | |
34 | 3255-3265 | Chemical | denotes | Remdisivir | |
35 | 3301-3311 | Chemical | denotes | Remdisivir | |
69 | 1277-1281 | Gene | denotes | RdRp | Gene:43740578 |
70 | 1470-1474 | Gene | denotes | RdRp | Gene:43740578 |
71 | 2503-2507 | Gene | denotes | RdRp | Gene:43740578 |
72 | 2897-2901 | Gene | denotes | RdRp | Gene:43740578 |
73 | 963-968 | Species | denotes | Ebola | Tax:1570291 |
74 | 993-1020 | Species | denotes | respiratory syncytial virus | Tax:12814 |
75 | 1064-1077 | Species | denotes | coronaviruses | Tax:11118 |
76 | 1088-1096 | Species | denotes | SARS CoV | Tax:694009 |
77 | 1101-1109 | Species | denotes | MERS CoV | Tax:1335626 |
78 | 1420-1433 | Species | denotes | coronaviruses | Tax:11118 |
79 | 1435-1443 | Species | denotes | MERS-CoV | Tax:1335626 |
80 | 1445-1453 | Species | denotes | SARS-CoV | Tax:694009 |
81 | 1458-1468 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
82 | 2075-2088 | Species | denotes | coronaviruses | Tax:11118 |
83 | 2097-2105 | Species | denotes | MERS-CoV | Tax:1335626 |
84 | 2107-2115 | Species | denotes | SARS-CoV | Tax:694009 |
85 | 2120-2130 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
86 | 2705-2718 | Species | denotes | coronaviruses | Tax:11118 |
87 | 3067-3077 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
88 | 1022-1025 | Species | denotes | RSV | Tax:12814 |
89 | 867-877 | Chemical | denotes | remdesivir | MESH:C000606551 |
90 | 879-882 | Chemical | denotes | RDV | MESH:C000606551 |
91 | 1115-1125 | Chemical | denotes | Remdesivir | MESH:C000606551 |
92 | 1185-1188 | Chemical | denotes | RDV | MESH:C000606551 |
93 | 1196-1199 | Chemical | denotes | RDV | MESH:C000606551 |
94 | 1507-1510 | Chemical | denotes | RDV | MESH:C000606551 |
95 | 1537-1546 | Chemical | denotes | Adenosine | MESH:D000241 |
96 | 1561-1564 | Chemical | denotes | ATP | MESH:D000255 |
97 | 1699-1702 | Chemical | denotes | RDV | MESH:C000606551 |
98 | 1884-1887 | Chemical | denotes | RDV | MESH:C000606551 |
99 | 2368-2371 | Chemical | denotes | RDV | MESH:C000606551 |
100 | 2670-2676 | Chemical | denotes | serine | MESH:D012694 |
101 | 2984-2987 | Chemical | denotes | RDV | MESH:C000606551 |
104 | 3567-3572 | Species | denotes | human | Tax:9606 |
105 | 3520-3535 | Disease | denotes | viral infection | MESH:D001102 |